Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo







Vol. 24, No. 3-4, 2006 

View or print article as PDF (88 KB)   
 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 16849858)
Medline Related Articles
Download Citation

Paper

Pediatric Gastrointestinal Motility - Future Directions and Challenges
Nader N. Youssefa, Carlo Di Lorenzob

aDivision of Pediatric Gastroenterology, Goryeb Children's Hospital/Atlantic Health System/University of Medicine and Dentistry of New Jersey Morristown, Morristown, N.J., and
bDivision of Pediatric Gastroenterology, Columbus Children's Hospital/The Ohio State University Columbus, Columbus, Ohio, USA

Address of Corresponding Author

Dig Dis 2006;24:308-312 (DOI: 10.1159/000092884)


 goto top of outline Key Words

  • Pediatric gastrointestinal motility
  • Neurogastroenterology
  • Pharmacogenomics
  • Children

 goto top of outline Abstract

The study of gastrointestinal motility has evolved to a sophisticated diagnostic technique that is widely used clinically to further guide management of children with complex gastrointestinal problems. Thorough comprehension requires a multidisciplinary approach with the integration of molecular and cell biology, organ physiology, and clinical observations. During the past decade there has been a dramatic increase in our knowledge of the enteric neuromuscular system. Continued exploration of targeted gene mutations in animal models has the potential of enhancing our understanding of congenital disorders of gastrointestinal motility. Experiments studying polymorphisms in serotonin transporter gene (SERT) and different therapeutic responses to serotonergic agents in adults with irritable bowel syndrome need to be carried out in children with functional bowel disorders. Additional considerations that need to be addressed if advances are to continue include increasing the number of specialists interest in motility disorders and identifying funding sources to support the establishment of research consortiums among pediatric centers.

Copyright © 2006 S. Karger AG, Basel


 goto top of outline References


1.
Pensabene L, Youssef NN, Griffiths J, Di Lorenzo C: Colonic manometry in children with defecatory disorders. Role in diagnosis and management. Am J Gastroenterol 2003;5:1052-1057.

2.
Hutson JM, Chow CW, Hurley MR, Wheatley JM, Catto-Smith AG: Deficiency of substance P-immunoreactive nerve fibres in children with intractable constipation: a form of intestinal neuronal dysplasia. J Paediatr Child Health 1997;3:187-189.External Resources

3.
Meier-Ruge WA, Holschneider AM, Scharli AF: New pathogenetic aspects of gut dysmotility in aplastic and hypoplastic desmosis of early childhood. Pediatr Surg Int 2001;2:140-143.External Resources

4.
Sabri MT, Barksdale E, Di Lorenzo C: Constipation and lack of colonic interstitial cells of Cajal. Dig Dis Sci 2003;5:849-853.External Resources

5.
Levy RL, Jones KR, Whitehead WE, Feld SI, Talley NJ, et al: Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology 2001;4:799-804.External Resources

6.
Coutinho SV, Plotsky PM, Sablad M, Miller JC, Zhou H, et al: Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat. Am J Physiol 2002;2:G307-G316.

7.
Gershon MD: Serotonin receptors and transporters - roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 2004;S7:3-14.External Resources

8.
Talley NJ: Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications. Aliment Pharmacol Ther 1992;3:273-289.

9.
Gestblom C, Sweetser DA, Doggett B, Kapur RP: Sympathoadrenal hyperplasia causes renal malformations in Ret (MEN2B)-transgenic mice. Am J Pathol 1999;6:2167-2179.

10.
Park MI, Camilleri M: Genetics and genotypes in irritable bowel syndrome: implications for diagnosis and treatment. Gastroenterol Clin North Am 2005;34:305-317.External Resources

11.
Di Lorenzo C, Benninga MA, Forbes D, Morais CB, Morera C, Rudolph C, et al: Functional gastrointestinal disorders, gastroesophageal reflux and neurogastroenterology: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2004;39:S616-S625.External Resources

12.
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-99-004.html

13.
Rudolph CD, Winter HS: NASPGN guidelines for training in pediatric gastroenterology. NASPGN Executive Council, NASPGN Training and Education Committee. J Pediatr Gastroenterol Nutr 1999;29:S1-S26.External Resources

14.
Li BU, Altschuler SM, Berseth CD, Di Lorenzo C, Rudolph CD, et al: Research Agenda for Motility and Functional Disorders: Report of NASPGHAN to the Children's Digestive Heath Foundation. J Pediatr Gastroenterol Nutr 2003;35:S263-S267.External Resources

15.
Sood MR, Schwankovsky LM, Rowhani A, Zangen T, Ziring D, Furtado T, et al: Water load test in children. J Pediatr Gastroenterol Nutr 2002;35:199-201.External Resources

16.
Chitkara DK, Camilleri M, Zinsmeister AR, Burton D, El-Youssef M, Freese D, et al: Gastric sensory and motor dysfunction in adolescents with functional dyspepsia. J Pediatr 2005;146:500-505.External Resources

17.
De Schepper DU, Cremonini F, Chitkara DK, Camilleri M: Assessment of gastric accommodation: overview and evaluation of current methods. Neurogastroenterol Motil 2004;16:275-285.External Resources

18.
Kauffman RE: Status of drug approval processes and regulation of medications for children. Curr Opin Pediatr 1995;7:195-198.External Resources

19.
Bonetta L: Pediatric study of medicines becomes mandatory. Nat Med 2000;10:1069.External Resources

20.
Rasquin-Weber A, Hyman PE, Cucchiara S, Fleisher DR, Hyams JS, Milla PJ, et al: Childhood functional gastrointestinal disorders. Gut 1999;45(suppl 2):60-68.

21.
Saps M, Di Lorenzo C: Interobserver and intraobserver reliability of the Rome II criteria in children. Am J Gastroenterol 2005;100:2079-2082.External Resources

22.
Caplan A, Walker L, Rasquin A: Validation of the Pediatric Rome II Criteria for Functional Gastrointestinal Disorders Using the Questionnaire on Pediatric Gastrointestinal Symptoms. J Pediatr Gastroenterol Nutr 2005;3:305-316.

23.
Burns DG. The risk of abdominal surgery in irritable bowel syndrome. S Afr Med J 1986;2:91.

24.
Vitiello B, Jensen PS: Medication development and testing in children and adolescents. Arch Gen Psychiatry 1997;54:871-876.External Resources

25.
Harth SC, Thong, YH: Parental perceptions and attitudes about informed consent in clinical research involving children. Soc Sci Med 1995;41:1645-1651.External Resources

26.
Van Ginkel R, Reitsma J, Buller H, van Wijk MK, Taminiau JA, Benninga MA: Childhood constipation: longitudinal follow-up beyond puberty. Gastroenterology 2003;125:357-363.External Resources


 goto top of outline Author Contacts

Nader N. Youssef, MD
Division of Pediatric Gastroenterology
Goryeb Children's Hospital, Atlantic Health System
100 Madison Avenue, Box 82, Morristown, NJ 07962 (USA)
Tel. +1 973 971 5676, Fax +1 973 290 7365, E-Mail Nader.Youssef@ahsys.org


 goto top of outline Article Information

Number of Print Pages : 5
Number of Figures : 0, Number of Tables : 1, Number of References : 26


 goto top of outline Publication Details

Digestive Diseases (Clinical Reviews)

Vol. 24, No. 3-4, Year 2006 (Cover Date: July 2006)

Journal Editor: Malfertheiner, P. (Magdeburg)
ISSN: 0257-2753 (print), 1421-9875 (Online)

For additional information: http://www.karger.com/DDI


 goto top of outline Drug Dosage / Copyright

Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.

   


copyright  © 2009 S. Karger AG, Basel
  Last update: 13/7/2006